These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10921519)

  • 1. Evidence that Alpers-Huttenlocher syndrome could be a mitochondrial disease.
    Rasmussen M; Sanengen T; Skullerud K; Kvittingen EA; Skjeldal OH
    J Child Neurol; 2000 Jul; 15(7):473-7. PubMed ID: 10921519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early mitochondrial encephalomyopathy due to complex IV deficiency consistent with Alpers-Huttenlocher syndrome: report of two cases].
    Castro-Gago M; González-Conde V; Fernández-Seara MJ; Rodrigo-Sáez E; Fernández-Cebrián S; Alonso-Martín A; Campos Y; Arenas J; Eirís-Puñal J
    Rev Neurol; 1999 Nov 16-30; 29(10):912-7. PubMed ID: 10637838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive cerebral degeneration of childhood with liver disease (Alpers Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation.
    Wörle H; Köhler B; Schlote W; Winkler P; Bastanier CK
    Clin Neuropathol; 1998; 17(2):63-8. PubMed ID: 9561326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial disorders: analysis of their clinical and imaging characteristics.
    Barkovich AJ; Good WV; Koch TK; Berg BO
    AJNR Am J Neuroradiol; 1993; 14(5):1119-37. PubMed ID: 8237691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity.
    Bicknese AR; May W; Hickey WF; Dodson WE
    Ann Neurol; 1992 Dec; 32(6):767-75. PubMed ID: 1471867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpers-huttenlocher syndrome: origins of clinicopathologic recognition.
    Rust RS
    Pediatr Neurol; 2013 Mar; 48(3):165-6. PubMed ID: 23419466
    [No Abstract]   [Full Text] [Related]  

  • 7. Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure.
    Delarue A; Paut O; Guys JM; Montfort MF; Lethel V; Roquelaure B; Pellissier JF; Sarles J; Camboulives J
    Pediatr Transplant; 2000 Feb; 4(1):67-71. PubMed ID: 10731063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate-induced liver failure in one of two siblings with Alpers disease.
    Schwabe MJ; Dobyns WB; Burke B; Armstrong DL
    Pediatr Neurol; 1997 May; 16(4):337-43. PubMed ID: 9258971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ragged red or ragged blue fibers.
    Reichmann H; Vogler L; Seibel P
    Eur Neurol; 1996; 36(2):98-102. PubMed ID: 8654494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketogenic diet in Alpers-Huttenlocher syndrome.
    Joshi CN; Greenberg CR; Mhanni AA; Salman MS
    Pediatr Neurol; 2009 Apr; 40(4):314-6. PubMed ID: 19302948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpers-Huttenlocher syndrome.
    Saneto RP; Cohen BH; Copeland WC; Naviaux RK
    Pediatr Neurol; 2013 Mar; 48(3):167-78. PubMed ID: 23419467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpers syndrome: progressive neuronal degeneration of children with liver disease.
    Gordon N
    Dev Med Child Neurol; 2006 Dec; 48(12):1001-3. PubMed ID: 17109792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of cell death in brain and liver, the target tissues of progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher disease).
    Simonati A; Filosto M; Savio C; Tomelleri G; Tonin P; Dalla Bernardina B; Rizzuto N
    Acta Neuropathol; 2003 Jul; 106(1):57-65. PubMed ID: 12721699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene.
    Pronicka E; Weglewska-Jurkiewicz A; Pronicki M; Sykut-Cegielska J; Kowalski P; Pajdowska M; Jankowska I; Kotulska K; Kalicinski P; Jakobkiewicz-Banecka J; Wegrzyn G
    Med Sci Monit; 2011 Apr; 17(4):CR203-9. PubMed ID: 21455106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial respiratory-chain defects presenting as nonspecific features in children.
    Tsao CY; Mendell JR; Lo WD; Luquette M; Rusin J
    J Child Neurol; 2000 Jul; 15(7):445-8. PubMed ID: 10921514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early muscle and brain ultrastructural changes in polymerase gamma 1-related encephalomyopathy.
    Nolte KW; Trepels-Kottek S; Honnef D; Weis J; Bien CG; van Baalen A; Ritter K; Czermin B; Rudnik-Schöneborn S; Wagner N; Häusler M
    Neuropathology; 2013 Feb; 33(1):59-67. PubMed ID: 22537151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults.
    Harding BN; Alsanjari N; Smith SJ; Wiles CM; Thrush D; Miller DH; Scaravilli F; Harding AE
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):320-5. PubMed ID: 7897414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders.
    Saneto RP; Lee IC; Koenig MK; Bao X; Weng SW; Naviaux RK; Wong LJ
    Seizure; 2010 Apr; 19(3):140-6. PubMed ID: 20138553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset of Alpers-Huttenlocher syndrome: an unusual cause of refractory epilepsy and liver failure.
    London F; Hadhoum N; Outteryck O; Vermersch P; Zéphir H
    Acta Neurol Belg; 2017 Mar; 117(1):399-401. PubMed ID: 27422324
    [No Abstract]   [Full Text] [Related]  

  • 20. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease.
    Cardenas JF; Amato RS
    Semin Pediatr Neurol; 2010 Mar; 17(1):62-4. PubMed ID: 20434700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.